Managing Brain Metastases in HER2-Positive Breast Cancer
Author Information
Author(s): Claudia von Arx, Claudia Calderaio, Alessandra Calabrese, Benedetta Marciano, Claudia Martinelli, Vincenzo Di Lauro, Ivana Cerillo, Daniela Cianniello, Michelino De Laurentiis
Primary Institution: Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy
Hypothesis
What are the current and future treatment strategies for HER2-positive breast cancer brain metastases?
Conclusion
The review highlights the need for multidisciplinary approaches to improve outcomes for patients with HER2-positive breast cancer brain metastases.
Supporting Evidence
- HER2-positive breast cancer patients with brain metastases have worse survival outcomes compared to those with metastases outside the brain.
- New drugs have shown strong efficacy in controlling brain metastases in HER2-positive breast cancer.
- Multidisciplinary management is essential for optimizing treatment strategies for brain metastases.
Takeaway
This study talks about how doctors can better treat patients with brain cancer that started from breast cancer, especially those with a specific type called HER2-positive.
Methodology
This is a review article discussing various treatment strategies and future directions for managing brain metastases in HER2-positive breast cancer.
Limitations
The review is based on existing literature and may not cover all recent developments in the field.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website